Yi Wang | Medicine | Research Excellence Award

Prof. Dr. Yi Wang | Medicine | Research Excellence Award

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | China

Prof. Dr. Yi Wang is a Professor and Principal Investigator at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, with a strong academic foundation in respiratory medicine and translational biomedical research. His education and professional training have shaped a focused career dedicated to understanding complex lung diseases, particularly pulmonary fibrosis. With extensive experience leading independent research groups, he has made significant contributions to uncovering molecular and cellular mechanisms underlying fibrotic lung remodeling. His research interests include DNA methylation, endoplasmic reticulum stress, macrophage–fibroblast interactions, gene therapy, and targeted drug delivery systems for respiratory diseases. Prof. Wang has published more than 28 high-impact scientific articles in leading international journals such as Nature Communications and the European Respiratory Journal. His work has been recognized through prestigious honors, including the National Science Fund for Excellent Young Scholars, alongside multiple national and provincial research grants. Overall, Prof. Wang’s research advances both fundamental understanding and therapeutic innovation in pulmonary fibrosis.

Citation Metrics (Scopus)

8000

6000

4000

2000

0

Citations
7,502

Documents
111

h-index
33

View Scopus Profile

Featured Publications

Autophagy Related 5 Promotes Mitochondrial Fission and Inflammation via HSP90-HIF-1α-Mediated Glycolysis in Kidney Fibrosis
Advanced Science, 2025
Kynurenine Acts as a Signaling Molecule to Attenuate Pulmonary Fibrosis by Enhancing the AHR-PTEN Axis
Journal of Advanced Research, 2025
Kdm2a Inhibition in Skeletal Muscle Improves Metabolic Flexibility in Obesity
Nature Metabolism, 2025
Effect of Roxadustat on Lowering Blood Lipids in Peritoneal Dialysis Patients with Anemia: A Multicenter Randomized Controlled Study
Renal Failure, 2025
Correlation Between Protein-Energy Wasting and Major Adverse Cardiovascular Events in Maintenance Hemodialysis Patients
Renal Failure, 2025

Yangyang Han | Nanomaterials | Research Excellence Award

Prof. Yangyang Han | Nanomaterials | Research Excellence Award

Shandong Second Medical University, China

Prof. Yangyang Han is a distinguished scholar and influential educator whose work spans biochemistry, molecular biology, and biomechanics. He holds a Ph.D. and has built a strong academic foundation that supports his role as a Professor and Master’s Supervisor. Over the years, he has served in several notable capacities, including Associate Professor, Lecturer, and Senior Visiting Scholar at the Institute of Mechanics, Chinese Academy of Sciences, where he deepened his expertise in molecular mechanisms and biomechanical processes. His professional journey includes leadership as Director of the Molecular Biology Teaching and Research Section and service as a Review Expert for the National Natural Science Foundation of China, reflecting his credibility in scientific evaluation and research guidance. As Leader of the Youth Innovation Team of Shandong Provincial Institutions of Higher Education and a Director within the Shandong Society of Biochemistry and Molecular Biology, he continues to foster scientific development and interdisciplinary collaboration. His research interests focus on molecular regulation, cellular biomechanics, and biomedical innovation, contributing to impactful advancements in the field. With recognition for his academic leadership and scientific service, Prof. Han remains committed to driving research excellence, nurturing emerging scholars, and advancing knowledge in life sciences.

Profiles: Scopus | Orcid

Featured Publications

Bai, L., Qian, X., Zhang, H., Yuan, Y., Cui, X., Cheng, M., & Han, Y. (2025). Plectin, a novel regulator in migration, invasion and adhesion of ovarian cancer. Cell & Bioscience. https://doi.org/10.1186/s13578-025-01349-2

Han, Y. (2020). RNA-seq reveals the diverse effects of substrate stiffness on epidermal ovarian cancer cells. Aging. https://doi.org/10.18632/aging.103906

Han, Y. (2020). Elevated microRNA-125b inhibits cytotrophoblast invasion and impairs endothelial cell function in preeclampsia. Cell Death Discovery. https://doi.org/10.1038/s41420-020-0269-0

 

Aléxia Thamara Gasparin | Diagnostic | Research Excellence Award

Mrs. Aléxia Thamara Gasparin | Diagnostic | Research Excellence Award

Hilab | Brazil

Mrs. Aléxia Thamara Gasparin is a dedicated biotechnology and pharmacology professional whose academic and research journey reflects strong commitment to scientific advancement and health innovation. She holds a technical qualification in Biotechnology and Industrial Bioprocesses from SENAI-PR, a Bachelor’s degree in Biological Sciences from the Federal University of Paraná (UFPR), and a Master’s degree in Pharmacology from UFPR. Throughout her education, she developed extensive laboratory expertise, particularly in evaluating the pharmacological potential and adverse effects of bioactive compounds, and she actively participated in specialized training programs in pharmacology, psychopharmacotherapy, epigenetics, and animal handling. Her professional experience includes significant contributions to research projects focused on antinociceptive and anti-inflammatory mechanisms, as well as the development of interactive and didactic scientific materials. She also played a key role in science outreach and health-related extension activities. Currently, she is part of the research and development team at Hilab, where she contributes to the innovation of remotely operated laboratory tests (RTL) and internationally patented products designed to expand access to healthcare technologies in Brazil. Her achievements include top rankings and awards in scientific presentation events, highlighting her proficiency and dedication. Aléxia continues to build a meaningful career focused on pharmacology, biotechnology, and health democratization.

Profile: Scopus

Featured Publication

Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis

Author: Cannabis and Cannabinoid Research

Year: 2024